People · Operator
Named in public records as an officer, director or promoter · active 2012–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Innovus Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $15.7M | $98.2M | 2012 |
Ziad Mirza at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ziad Mirza on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Henry Esber | 1 | 2 |
| Vivian Liu | 1 | 2 |
| Wallace Boyack | 1 | 1 |
| Bassam Damaj | 1 | 1 |
| Vivian Reed Liu | 1 | 1 |
| Henry Reed Esber | 1 | 1 |
| Bassam Reed Damaj | 1 | 1 |
| Ziad Reed Mirza | 1 | 1 |
| Morgan Reed Brown | 1 | 1 |
| Ryan Selhorn | 1 | 1 |
| Randy Berholtz | 1 | 1 |
| Dean Nuhaily | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.